Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Willmar Schwabe is a global leader in the research, development, and production of herbal medicines, commonly referred to as phytopharmaceuticals. Founded in 1866 and based in Karlsruhe, Germany, the family-owned company is best known for its standardized Ginkgo biloba extract, EGb 761, which is used worldwide for cognitive disorders. The Schwabe Group maintains a vertically integrated value chain, encompassing everything from the cultivation of medicinal plants to specialized extraction processes and extensive clinical testing. Its product portfolio includes prominent brands such as Tebonin, Lasea, and Umckaloabo, which address conditions in neurology, psychiatry, and respiratory medicine. With a commitment to Phytoneering, the company bridges the gap between traditional herbal knowledge and modern pharmaceutical standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Willmar Schwabe Extracta.